Press Release | April 18, 2023
ImCheck Achieves the Primary Objectives of Phase I of the EVICTION-2 Trial of ICT01 in Combination with Low Dose IL-2, Data Presented at AACR 2023
Read More
News | April 16, 2023
Dragonfly Therapeutics Announces the Publication of Preclinical Data
Read More
Press Release | April 13, 2023
Caris Life Sciences and Flare Therapeutics Announce Strategic Preferred Portfolio Partnership to Advance Flare’s Precision Oncology Pipeline
Read More
News | March 26, 2023
Investing long-term in the cell & gene therapies of the future
Read More